Pri-Med Southwest - Primary Care CME/CE Conference & Expo

Houston, TX | April 5-7, 2022

George R. Brown Convention Center

Disclosures

The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation. 

Financial Disclosures

Martin J. Abrahamson, MD, FACP
Novo Nordisk, Advisor
Charles E. Argoff, MD, FABPM
AbbVie, Researcher; AbbVie, Speaker; Allergan, Researcher; Amgen, Advisor; Amgen, Researcher; Amgen, Speaker; BioDelivery Sciences International, Inc., Advisor; Biohaven, Speaker; Biohaven, Speaker; Clexio Biosciences, Advisor; Collegium, Other; EnZen Therapeutics, Consultant; Lilly, Researcher; Lilly, Speaker; Lundbeck, Researcher; Neumentum, Advisor; Nevro, Advisor; Nevro, Speaker; Opioid PMR Consortium, Consultant; Redhill Pharma, Speaker; Regeneron Pharmaceuticals, Advisor; SK Life Sciences, Advisor; Teva, Researcher; Teva, Speaker; Teva Pharmaceuticals, Advisor; Tremeau Pharmaceuticals, Inc., Advisor; Vertex, Advisor; XGene Pharma, Consultant
Robert L. Atmar, MD
Takeda Vaccines, Inc., Researcher
Christie M. Ballantyne, MD, FACP, FACC
Althera, Consultant; Amarin Pharma, Inc., Consultant; Arrowhead, Consultant; Arrowhead, Consultant; Arrowhead, Researcher; Astra Zeneca, Consultant; Esperion, Consultant; Genentech, Consultant; Gilead, Consultant; Ionis, Researcher; Matinas BioPharma Inc., Consultant; Merck, Consultant; New Amsterdam, Consultant; Novartis, Consultant; Novartis, Researcher; Novo Nordisk, Consultant; Novo Nordisk, Researcher; Pfizer, Consultant; Sanofi-Synthelabo, Consultant
Lauren S. Blieden, MD
Aerie Pharmaceuticals, Advisor; Allergan, Inc., Advisor
Angela Catic, MD, MEd
No relevant financial relationships disclosed.
Sanjiv Chopra, MD, MACP
No relevant financial relationships disclosed.
Armando G. Correa, MD, FAAP
No relevant financial relationships disclosed.
Oscar A. de Leon-Casasola, MD
Esteve Pharma, Advisor; Heron Therapeutics, Advisor; Medtronic, Advisor; Tremeau Pharma, Advisor
Frank J. Domino, MD
No relevant financial relationships disclosed.
Hana El Sahly, MD
No relevant financial relationships disclosed.
Katherine E. Galluzzi, DO, CMD, FACOFP
No relevant financial relationships disclosed.
Ty J. Gluckman, MD, FACC, FAHA
No relevant financial relationships disclosed.
Jennifer B. Green, MD
AstraZeneca, Consultant; Bayer, Consultant; Boehringer Ingelheim/Lilly, Consultant; Boehringer Ingelheim/Lilly, Researcher; Hawthorn Effect/Omada, Consultant; Merck & Co. Inc., Researcher; Novo Nordisk, Inc., Consultant; Pfizer, Consultant; Roche, Researcher; Sanofi/Lexicon, Consultant; Sanofi/Lexicon, Researcher
Stephen N. Henry, DO, MS
No relevant financial relationships disclosed.
Prathit A. Kulkarni, MD
Vessel Health, Inc., Researcher
Anupam Kumar, MD, FCCP
No relevant financial relationships disclosed.
Doris Kung, DO
No relevant financial relationships disclosed.
Petros Levounis, MD, MA
No relevant financial relationships disclosed.
Marco Marcelli, MD
No relevant financial relationships disclosed.
Sanjay N. Mediwala, MD
No relevant financial relationships disclosed.
Travis Mills
No relevant financial relationships disclosed.
Dharani Narendra, MD
No relevant financial relationships disclosed
Saundra Nguyen, MD, MPH
No relevant financial relationships disclosed.
Jeffrey Rado, MD, MPH, FAPA
No relevant financial relationships disclosed.
Rajeev Raghavan, MD
Bayer, Speaker; Reata Pharmaceuticals, Inc., Advisor; Travere, Consultant
Vicky Ren, MD
No relevant financial relationships disclosed
R. Michelle Schmidt, MD, MPH
No relevant financial relationships disclosed.
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Boehringer Ingelheim Pharmaceuticals, Inc., Consultant; Calibrate, Advisor; Coral Health, Advisor; Gelesis, Consultant; GoodRx, Advisor; Lilly USA, LLC, Consultant; Novo Nordisk Inc., Consultant; Pfizer Inc., Consultant
Peter P. Toth, MD, PhD
Amarin Pharma Inc., Advisor; Kowa Pharmaceuticals America, Inc., Advisor; Novartis Pharmaceuticals Corporation, Advisor; Novo Nordisk, Speaker; Resverlogix, Advisor
Shirah Vollmer, MD
No relevant financial relationships disclosed.
Daniel Y. Wang, MD
Regeneron, Advisor; Sanofi-Genzyme, Advisor; Tessa Therapeutics, Researcher
Karol E. Watson, MD, PhD
Amarin Pharma Inc., Consultant; Amgen Inc., Consultant; Boehringer Ingelheim Pharmaceuticals, Inc., Consultant; Boehringer Ingelheim Pharmaceuticals, Inc., Speaker; Esperion Therapeutics, Consultant; Lilly USA, LLC, Consultant; Lilly USA, LLC, Speaker
Jennifer Whitaker, MD, MS
No relevant financial relationships disclosed.

Other Disclosures

Richard Hamill, MD (Course Co-Chair): Consultant with Moderna. 

Pamela Kushner, MD, FAAFP (Reviewer): Speaker/Advisor/Consultant with AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Lilly, Janssen, and Novo Nordisk. Speaker with Bayer. Advisor with Abbott, Intuity Medical, Phathom, and Pfizer. Stock Holder with Abbott, AstraZeneca, and Lilly.

All other non-faculty contributors involved in the planning, development, editing and review of the content have disclosed no relevant financial relationships.